UK Modern Slavery Act Disclosure

This statement is made in accordance with Section 54(1) of the Modern Slavery Act 2015 (the “Act”) and constitutes the Modern Slavery and Human Trafficking Statement for BioCryst UK Limited (“BioCryst”) on behalf of itself and those of its affiliates that are subject to the Act. It relates to the financial year ending 31 December 2021.

BioCryst is a commercial-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives. With expertise in drug discovery, clinical development, and regulatory affairs, we are advancing clinical programs and generating new compounds from our own discovery engine. We are passionate about advancing novel therapeutics for patients with rare and serious diseases and proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. BioCryst’s US headquarters are located in Durham, North Carolina, our European headquarters in Dublin, Ireland and our Discovery Center of Excellence in Birmingham, Alabama.

BioCryst is committed to upholding a safe work environment and overseeing our operations ethically, lawfully, and to the highest standards of business conduct. Directors, officers and employees are all required to comply with the BioCryst Code of Business Conduct. We require our employees to conduct their scientific and business activities in a manner consistent with the highest ethical, professional and legal standards. Violations of BioCryst’s Code of Business Conduct policies will not be tolerated and will result in disciplinary action, including termination of employment where appropriate.

We expect our employees to utilize our Compliance Alert Line to anonymously report any suspected misconduct or unlawful activity. Any such reports shall be properly investigated and resolved. BioCryst believes in the importance of protecting human rights within our global supply chain. Our direct supply chain consists of suppliers located primarily within [North America and Western Europe]. BioCryst further expects its suppliers to abide by the BioCryst Code of Business Conduct and this includes the obligation to comply with the letter and spirit of all applicable international laws and regulations. The Code of Business Conduct further includes a responsibility for assuring that every employee is welcomed, accepted and rewarded according to his or her contribution. In the past year, we continued to publicize our Code of Business Conduct standards through communications and awareness building with our supplier facing resources with the expectation that they educate and manage our suppliers accordingly. BioCryst shall terminate our relationship with suppliers failing to comply with the standards set forth.

This past year, we continued our practice of visiting a large portion of our direct supply base for general business and quality audit purposes which included interactions with the employees of those suppliers. We further hired more supply chain managers to increase our visibility and interaction with our suppliers.

BioCryst remains committed to playing our part in preventing any act of modern slavery within our global supply chain.


Luke Robinson
General Manager, UK, Ireland & Nordics
BioCryst UK Limited